The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Freeman, M. P.
* Articles by Stoll, A. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Freeman, M. P.
* Articles by Stoll, A. L.
Am J Psychiatry 155:12-21, January 1998
© 1998 American Psychiatric Association


Special Articles

Mood Stabilizer Combinations: A Review of Safety and Efficacy

Marlene P. Freeman, M.D., and Andrew L. Stoll, M.D.

OBJECTIVE: Polypharmacy is common in the treatment of refractory bipolar disorder. The purpose of this article is to review the safety and efficacy of mood stabilizers in combinations. METHOD: A manual and computer (MEDLINE) search was performed for combinations of the most commonly used mood-stabilizing agents. RESULTS: The authors review safety and efficacy data on the more frequently encountered combinations of established and putative mood stabilizers. CONCLUSIONS: There have been few controlled studies of the use of combinations of mood stabilizers. The interactions of such combinations are sometimes complex, often very useful, and potentially dangerous. One general rule that may reduce the risks of toxic drug interactions is to add medication to the patient's current regimen in modest doses and increase the dose slowly. The safest and most efficacious mood stabilizer combinations appear to be the mixtures of anticonvulsants and lithium, particularly valproate plus lithium. Once the mechanisms of the mood stabilizers are identified, it is possible that a more rational approach to combination therapy will emerge, based on synergism at the sites of action. (Am J Psychiatry 1998; 155:12–21)




This article has been cited by other articles:


Home page
J. Neurosci.Home page
Y. Leng, M.-H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.-M. Chuang
Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition
J. Neurosci., March 5, 2008; 28(10): 2576 - 2588.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
F. M. Sanchez and M. H. Zisselman
Treatment of Psychiatric Symptoms Associated With Neurosyphilis
Psychosomatics, October 1, 2007; 48(5): 440 - 445.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
G. S. Sachs
Bipolar Disorder Clinical Synthesis: Where Does the Evidence Lead?
Focus, January 1, 2007; 5(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
M. Gitlin
Treatment-Resistant Bipolar Disorder
Focus, January 1, 2007; 5(1): 49 - 63.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
J. Cookson and B. Elliott
The use of anticonvulsants in the aftermath of mania
J Psychopharmacol, March 1, 2006; 20(2_suppl): 23 - 30.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
I. M. Salloum, J. R. Cornelius, D. C. Daley, L. Kirisci, J. M. Himmelhoch, and M. E. Thase
Efficacy of Valproate Maintenance in Patients With Bipolar Disorder and Alcoholism: A Double-blind Placebo-Controlled Study
Arch Gen Psychiatry, January 1, 2005; 62(1): 37 - 45.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R.H. Belmaker
Bipolar Disorder
N. Engl. J. Med., July 29, 2004; 351(5): 476 - 486.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. H. Williams and D. L. Hepner
Risperidone and Exaggerated Hypotension During a Spinal Anesthetic
Anesth. Analg., January 1, 2004; 98(1): 240 - 241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
D. J. Safer, J. M. Zito, and S. dosReis
Concomitant Psychotropic Medication for Youths
Am J Psychiatry, March 1, 2003; 160(3): 438 - 449.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
L. N. YATHAM, F. GROSSMAN, I. AUGUSTYNS, E. VIETA, and A. RAVINDRAN
Mood stabilisers plus risperidone or placebo in the treatment of acute mania: International, double-blind, randomised controlled trial
The British Journal of Psychiatry, February 1, 2003; 182(2): 141 - 147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. S. Sachs, F. Grossman, S. N. Ghaemi, A. Okamoto, and C. L. Bowden
Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety
Am J Psychiatry, July 1, 2002; 159(7): 1146 - 1154.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. Tohen, K. N. R. Chengappa, T. Suppes, C. A. Zarate Jr, J. R. Calabrese, C. L. Bowden, G. S. Sachs, D. J. Kupfer, R. W. Baker, R. C. Risser, et al.
Efficacy of Olanzapine in Combination With Valproate or Lithium in the Treatment of Mania in Patients Partially Nonresponsive to Valproate or Lithium Monotherapy
Arch Gen Psychiatry, January 1, 2002; 59(1): 62 - 69.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
H. K. MANJI, G. J. MOORE, and G. CHEN
Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers
The British Journal of Psychiatry, June 1, 2001; 178 (41): s107 - s119.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
T. A. Mellman, A. L. Miller, E. M. Weissman, M. L. Crismon, S. M. Essock, and S. R. Marder
Evidence-Based Pharmacologic Treatment for People With Severe Mental Illness:A Focus on Guidelines and Algorithms
Psychiatr Serv, May 1, 2001; 52(5): 619 - 625.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
I N. Ferrier
Developments in mood stabilisers: Depression and public health
Br. Med. Bull., March 1, 2001; 57(1): 179 - 192.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
A. Clark
Proposed treatment for adolescent psychosis. 2: Bipolar illness
Adv. Psychiatr. Treat., March 1, 2001; 7(2): 143 - 149.
[Full Text]


Home page
Psychiatr. Serv.Home page
L. Citrome, J. Levine, and B. Allingham
Changes in Use of Valproate and Other Mood Stabilizers for Patients With Schizophrenia From 1994 to 1998
Psychiatr Serv, May 1, 2000; 51(5): 634 - 638.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
E. Leibenluft and T. Suppes
Treating Bipolar Illness: Focus on Treatment Algorithms and Management of the Sleep-Wake Cycle
Am J Psychiatry, December 1, 1999; 156(12): 1976 - 1981.
[Full Text]


Home page
PsychosomaticsHome page
A. Monji, I. Yoshida, H. Koga, K.-i. Tashiro, and N. Tashiro
Brain Injury-Induced Rapid-Cycling Affective Disorder Successfully Treated With Valproate
Psychosomatics, October 1, 1999; 40(5): 448 - 449.
[Full Text]


Home page
Am. J. PsychiatryHome page
H.-Y. LANE, W.-C. CHIU, and W.-H. CHANG
Risperidone Monotherapy for Mania and Depression
Am J Psychiatry, July 1, 1999; 156(7): 1115 - 1115.
[Full Text]


Home page
Am. J. PsychiatryHome page
R. W. LOVELL
Mood Stabilizer Combinations for Bipolar Disorder
Am J Psychiatry, June 1, 1999; 156(6): 980a - 980.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org